申请人:Merck & Co., Inc.
公开号:EP0278158A2
公开(公告)日:1988-08-17
Peptides of the formula:
which comprise novel elements replacing the Phe(8)-His(9) sequence in renin-inhibitory peptides based on substrate analogy, which inhibit the substrate-cleaving action of renin and have improved bioavailability; compositions containing these renin-inhibitory peptides, optionally with other antihypertensive agents; and methods of treating hypertension or congestive heart failure or of establishing renin as a causative factor in these problems which employ the novel peptides.
式中的肽,其包含的新型元素取代了基于底物类比的肾素抑制肽中的Phe(8)-His(9)序列,可抑制肾素的底物清除作用,并具有更好的生物利用度;含有这些肾素抑制肽的组合物,可选择与其他降压药一起使用;以及治疗高血压或充血性心力衰竭或确定肾素是这些问题的致病因素的方法,其中采用了新型肽。